1 option
CADTH Canadian Drug Expert Committee recommendation : indication : for use in combination with methotrexate (MTX) for the treatment of adult patients with moderate to severe rheumatoid arthritis (RA) who have responded inadequately to one or more disease-modifying anti-rheumatic drugs (DMARDs) : baricitinib may also be used as monotherapy in cases of intolerance to MTX. Baricitinib (Olumiant -- Eli Lilly Canada Inc.) / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author, issuing body.
- Series:
- CADTH common drug review.
- CADTH Common Drug Review
- Language:
- English
- Subjects (All):
- Outcome assessment (Medical care).
- Physical Description:
- 1 online resource.
- Edition:
- First edition.
- Place of Publication:
- Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2019.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.